KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia

Blood

Volumn 124, Issue 5, 2014, Pages 803-811

  Liu, Dun ^a   Zhang, Xinhua ^b   Yu, Lihua ^a   Cai, Ren ^c   Ma, Xiaoxia ^a   Zheng, Chengguang ^d   Zhou, Yuqiu ^e   Liu, Qiji ^f   Wei, Xiaofeng ^a   Lin, Li ^a   Yan, Tizhen ^c   Huang, Jiwei ^a   Mohandas, Narla ^g   An, Xiuli ^g   Xu, Xiangmin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b The 303rd Hospital of PLA   (China)

^c Liuzhou Women and Children's Hospital   (China)

^d Guangxi Zhuang Autonomous Region   (China)

^e Health Institute   (China)

^f SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^g NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; HEMOGLOBIN A; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN F; HISTIDINE; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 1; PROTEIN MYB; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; BETA THALASSEMIA; CHILD; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FRAMESHIFT MUTATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MISSENSE MUTATION; MUTATION RATE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; FETAL HEMOGLOBIN; HUMANS; INFANT; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MUTATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; ZINC FINGERS;

EID: 84905114321     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-03-561779     Document Type: Article

References (36)

1. Thein SL. The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011700.
2. Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. Lancet. 2012;379(9813):373-383.
3. Lettre G. The search for genetic modifiers of disease severity in the β-hemoglobinopathies. Cold Spring Harb Perspect Med. 2012;2(10):a015032.
4. Thein SL. Genetic association studies in β-hemoglobinopathies. Hematology Am Soc Hematol Educ Program. 2013;2013:354-361.
5. Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Lettre G. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010;42(12):1049-1051.
6. Viprakasit V, Tanphaichitr VS, Chinchang W, Sangkla P, Weiss MJ, Higgs DR. Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia. Blood. 2004;103(9):3296-3299. (Pubitemid 38525654)
7. Han AP, Fleming MD, Chen JJ. Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. J Clin Invest. 2005;115(6):1562-1570. (Pubitemid 40814664)
8. Galanello R, Sanna S, Perseu L, et al. Amelioration of Sardinian beta0 thalassemia by genetic modifiers. Blood. 2009;114(18):3935-3937.
9. Sankaran VG, Orkin SH. The switch from fetal to adult hemoglobin. Cold Spring Harb Perspect Med. 2013;3(1):a011643.
10. Zhou D, Liu K, Sun CW, Pawlik KM, Townes TM. KLF1 regulates BCL11A expression and gammato beta-globin gene switching. Nat Genet. 2010;42(9):742-744.
11. Arnaud L, Saison C, Helias V, et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet. 2010;87(5):721-727.
12. Viprakasit V, Ekwattanakit S, Riolueang S, et al. Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression. Blood. 2014;123(10):1586-1595. [Epub ahead of print].
13. Singleton BK, Lau W, Fairweather VS, et al. Mutations in the second zinc finger of human EKLF reduce promoter affinity but give rise to benign and disease phenotypes. Blood. 2011;118(11):3137-3145.
14. Siatecka M, Bieker JJ. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood. 2011;118(8):2044-2054.
15. Borg J, Patrinos GP, Felice AE, Philipsen S. Erythroid phenotypes associated with KLF1 mutations. Haematologica. 2011;96(5):635-638.
16. Borg J, Papadopoulos P, Georgitsi M, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet. 2010;42(9):801-805.
17. Satta S, Perseu L, Moi P, et al. Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin. Haematologica. 2011;96(5):767-770.
18. Gallienne AE, Dréau HM, Schuh A, Old JM, Henderson S. Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults. Haematologica. 2012;97(3):340-343.
19. Perseu L, Satta S, Moi P, et al. KLF1 gene mutations cause borderline HbA(2). Blood. 2011;118(16):4454-4458.
20. Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139-148.
21. Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of a and b thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517-522. (Pubitemid 38621798)
22. Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet. 2001;2(4):245-255. (Pubitemid 33674773)
23. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes. 4th ed. Oxford, UK: Blackwell Science; 2001.
24. Thuret I, Pondarré C, Loundou A, et al. Complications and treatment of patients with β-thalassemia in France: results of the National Registry. Haematologica. 2010;95(5):724-729.
25. Gilman JG, Huisman TH. DNA sequence variation associated with elevated fetal G gamma globin production. Blood. 1985;66(4):783-787. (Pubitemid 15242459)
26. Uda M, Galanello R, Sanna S, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of β-thalassemia. Proc Natl Acad Sci U S A. 2008;105(5):1620- 1625. (Pubitemid 351346564)
27. Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet. 2007;39(10):1197-1199. (Pubitemid 47482679)
28. Farrell JJ, Sherva RM, Chen ZY, et al. A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood. 2011;117(18):4935-4945.
29. Wang T, He Y, Zhou JY, et al. KLF1 gene mutations in Chinese adults with increased fetal hemoglobin. Hemoglobin. 2013;37(5):501-506.
30. Wang Z, Luo G, Ji Y. A novel 519-525dup mutation of KLF1 gene identified in a Chinese blood donor with Lu(a-b-) phenotype. Transfusion. 2013;53(7):1619-1620.
31. Helias V, Saison C, Peyrard T, et al. Molecular analysis of the rare in(Lu) blood type: toward decoding the phenotypic outcome of haploinsufficiency for the transcription factor KLF1. Hum Mutat. 2013;34(1):221-228.
32. Singleton BK, Burton NM, Green C, Brady RL, Anstee DJ. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood. 2008;112(5):2081-2088.
33. Weatherall DJ, Clegg JB. Genetic variability in response to infection: malaria and after. Genes Immun. 2002;3(6):331-337. (Pubitemid 38967560)
34. Tang L, Zhu P, Zhou WJ, et al. Development and validation of a zeta-globin-specific ELISA for carrier screening of the (- SEA) alpha thalassaemia deletion. J Clin Pathol. 2009;62(2):147-151.
35. van der Harst P, Zhang W, Mateo Leach I, et al. Seventy-five genetic loci influencing the human red blood cell. Nature. 2012;492(7429): 369-375.
36. Tallack MR, Magor GW, Dartigues B, et al. Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq. Genome Res. 2012;22(12):2385-2398.